Sankaijo BOTANICAL LAXATIVE (docusate sodium 8.33 mg and sennosides 1.36 mg) tablets, 150-count bottles, Manufactured by SATO PHARMACEUTICAL CO., LTD., 1-5-27 Motoakasaka Minato-KU Tokyo, Japan; SATO PHARMACEUTICAL, INC., 20695 S. Western Ave., Suite 240, Torrance, CA 90501; NDC 49873-404-01.
Published November 13, 2019 · Recall initiated: October 1, 2019
Summary
FDA records drug Class III recall D-0303-2020, published November 13, 2019 and initiated October 1, 2019. Recalling firm: Sato Pharmaceutical Inc.; Status: Terminated; Reported quantity: 17,284 bottles; Lot: Lot #: TXWT, Exp 01/20; TXTS, Exp 10/20; AXWS, Exp 10/21. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug: Formulated amount of sennosides component is less than labelled claim.
What to do
Voluntary: Firm initiated · Letter
Get an email if SANKAIJO has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- SANKAIJO
- Manufacturer
- Sato Pharmaceutical Inc.
- Distributor
- Nationwide in the USA and Guam and Saipan, Northern Mariana Islands
- Lot
- Lot #: TXWT, Exp 01/20; TXTS, Exp 10/20; AXWS, Exp 10/21
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAS-VIT B COMPLEX INJ SOLN (HP); Rx Only, 30ML glass vial, Red Mountain Compounding RxNovember 13, 2019
- FDACephalexin for Oral Suspension USP, 250 mg/5mL, 200 mL bottle, Rx only, Manufactured for: LupinNovember 13, 2019
- FDAS-TESTOSTERONE ULTRA 250MG/ML MDV IN SESAME OIL (TEST CYP 200MG/TEST PROP 25MG/NANDROLONE DECA 25MG) Rx Only,November 13, 2019
- FDACefdinir for Oral Suspension USP, 250 mg/5mL,100 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals,November 13, 2019
- FDAS-TEST CYP/NAN-DECA 200/50MG/ML MDV IN SESAME OIL; Rx Only, 10ml glass vial. Red Mountain Compounding RxNovember 13, 2019
- FDACefdinir for Oral Suspension USP, 125 mg/5mL, packaged in a) 60 mL bottle (NDC 68180-722-20), b) 100 mL bottleNovember 13, 2019
Questions about this recall
Was Sankaijo BOTANICAL LAXATIVE (docusate sodium 8.33 mg and sennosides 1.36 mg) tablets, 150-count bottles, Manufactured by SATO PHARMACEUTICAL CO., LTD., 1-5-27 Motoakasaka Minato-KU Tokyo, Japan; SATO PHARMACEUTICAL, INC., 20695 S. Western Ave., Suite 240, Torrance, CA 90501; NDC 49873-404-01. recalled?
Yes. FDA published recall D-0303-2020 on November 13, 2019. Reported hazard: Subpotent Drug: Formulated amount of sennosides component is less than labelled claim.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: SANKAIJO.